A detailed history of Victory Capital Management Inc transactions in Biogen Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 133,213 shares of BIIB stock, worth $23.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
133,213
Previous 135,254 1.51%
Holding current value
$23.2 Million
Previous $29.2 Million 5.89%
% of portfolio
0.03%
Previous 0.03%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$190.52 - $236.72 $388,851 - $483,145
-2,041 Reduced 1.51%
133,213 $30.9 Million
Q1 2024

May 03, 2024

BUY
$212.02 - $267.71 $870,554 - $1.1 Million
4,106 Added 3.13%
135,254 $29.2 Million
Q4 2023

Feb 05, 2024

SELL
$222.59 - $267.94 $663,763 - $798,997
-2,982 Reduced 2.22%
131,148 $33.9 Million
Q3 2023

Nov 06, 2023

BUY
$253.3 - $285.89 $6.17 Million - $6.97 Million
24,371 Added 22.2%
134,130 $34.5 Million
Q2 2023

Jul 27, 2023

SELL
$275.25 - $318.06 $8.43 Million - $9.74 Million
-30,614 Reduced 21.81%
109,759 $31.3 Million
Q1 2023

May 02, 2023

SELL
$256.56 - $292.34 $3.97 Million - $4.53 Million
-15,490 Reduced 9.94%
140,373 $39 Million
Q4 2022

Feb 10, 2023

BUY
$252.44 - $306.72 $1.44 Million - $1.75 Million
5,691 Added 3.79%
155,863 $43.2 Million
Q4 2022

Feb 09, 2023

SELL
$252.44 - $306.72 $3.38 Million - $4.1 Million
-13,373 Reduced 8.18%
150,172 $41.6 Million
Q3 2022

Nov 02, 2022

SELL
$194.69 - $268.46 $765,521 - $1.06 Million
-3,932 Reduced 2.35%
163,545 $43.7 Million
Q2 2022

Aug 01, 2022

BUY
$187.54 - $223.02 $332,883 - $395,860
1,775 Added 1.07%
167,477 $34.2 Million
Q1 2022

May 04, 2022

BUY
$193.77 - $244.14 $4.95 Million - $6.24 Million
25,556 Added 18.24%
165,702 $34.4 Million
Q4 2021

Feb 07, 2022

BUY
$223.92 - $287.77 $2.66 Million - $3.41 Million
11,863 Added 9.25%
140,146 $33.6 Million
Q3 2021

Nov 02, 2021

SELL
$282.99 - $369.05 $9.9 Million - $12.9 Million
-34,982 Reduced 21.43%
128,283 $36.3 Million
Q2 2021

Aug 03, 2021

SELL
$259.0 - $414.71 $1.79 Million - $2.86 Million
-6,900 Reduced 4.05%
163,265 $56.5 Million
Q1 2021

May 04, 2021

SELL
$242.95 - $284.63 $3.84 Million - $4.49 Million
-15,790 Reduced 8.49%
170,165 $47.6 Million
Q4 2020

Feb 01, 2021

SELL
$236.26 - $355.63 $2.67 Million - $4.02 Million
-11,300 Reduced 5.73%
185,955 $45.5 Million
Q3 2020

Nov 09, 2020

BUY
$264.77 - $305.71 $7.37 Million - $8.51 Million
27,829 Added 16.43%
197,255 $56 Million
Q2 2020

Aug 07, 2020

SELL
$258.66 - $342.55 $1.2 Million - $1.59 Million
-4,641 Reduced 2.67%
169,426 $45.3 Million
Q1 2020

May 04, 2020

SELL
$268.85 - $341.04 $11.8 Million - $15 Million
-43,867 Reduced 20.13%
174,067 $55.1 Million
Q4 2019

Feb 06, 2020

BUY
$220.06 - $304.07 $1.77 Million - $2.44 Million
8,026 Added 3.82%
217,934 $64.7 Million
Q4 2019

Feb 04, 2020

SELL
$220.06 - $304.07 $1.83 Million - $2.53 Million
-8,316 Reduced 3.81%
209,908 $56.4 Million
Q3 2019

Nov 12, 2019

BUY
$217.44 - $243.88 $35.2 Million - $39.4 Million
161,742 Added 286.36%
218,224 $50.8 Million
Q2 2019

Aug 15, 2019

SELL
$219.29 - $241.72 $143,196 - $157,843
-653 Reduced 1.14%
56,482 $13.2 Million
Q1 2019

May 03, 2019

BUY
$216.71 - $338.96 $1.1 Million - $1.72 Million
5,075 Added 9.75%
57,135 $13.5 Million
Q4 2018

Feb 05, 2019

BUY
$278.5 - $352.75 $8.53 Million - $10.8 Million
30,637 Added 143.01%
52,060 $15.7 Million
Q3 2018

Nov 01, 2018

BUY
$293.51 - $383.83 $5.35 Million - $6.99 Million
18,223 Added 569.47%
21,423 $7.57 Million
Q2 2018

Aug 02, 2018

SELL
$257.52 - $306.91 $17,253 - $20,562
-67 Reduced 2.05%
3,200 $929,000
Q1 2018

May 04, 2018

SELL
$260.13 - $367.91 $1.47 Million - $2.07 Million
-5,636 Reduced 63.3%
3,267 $895,000
Q4 2017

Feb 01, 2018

BUY
$307.64 - $344.58 $144,590 - $161,952
470 Added 5.57%
8,903 $2.84 Million
Q3 2017

Oct 27, 2017

BUY
$281.15 - $329.69 $160,255 - $187,923
570 Added 7.25%
8,433 $2.64 Million
Q2 2017

Aug 07, 2017

BUY
N/A
7,863
7,863 $2.13 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.